Neimeth International Pharmaceuticals Plc (NGX:NEIMETH)
Nigeria · Delayed Price · Currency is NGN 7.85
+0.15 (1.95%)
At close: Sep 25, 2026
NGX:NEIMETH Ratios and Metrics
Market cap in millions NGN. Fiscal year is January - December.
Millions NGN. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 |
| 37,603 | 24,784 | 9,785 | 8,290 | 2,716 | 2,659 | |
Market Cap Growth | 46.67% | 153.28% | 18.04% | 205.24% | 2.14% | -20.00% |
Enterprise Value | 45,753 | 27,906 | 11,901 | 9,264 | 5,237 | 4,683 |
Last Close Price | 7.70 | 5.34 | 2.11 | 1.79 | 1.32 | 1.29 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 |
PE Ratio | 33.57 | 25.38 | - | - | - | - |
PS Ratio | 4.63 | 3.36 | 2.18 | 3.75 | 0.93 | 0.98 |
PB Ratio | 13.26 | 9.43 | 5.92 | 3.27 | 3.49 | 2.43 |
P/TBV Ratio | 13.29 | 9.46 | 5.99 | 3.27 | 3.49 | 2.43 |
P/FCF Ratio | 28.80 | 20.16 | - | - | - | - |
P/OCF Ratio | 18.86 | 16.44 | 24.70 | - | 20.49 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 |
EV/Sales Ratio | 5.63 | 3.79 | 2.65 | 4.19 | 1.79 | 1.73 |
EV/EBITDA Ratio | 17.95 | 11.96 | 6.07 | 21.81 | 54.54 | 49.41 |
EV/EBIT Ratio | 19.43 | 12.86 | 6.50 | 31.01 | - | - |
EV/FCF Ratio | 35.04 | 22.70 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 |
Debt / Equity Ratio | 3.29 | 3.66 | 3.26 | 1.73 | 4.68 | 3.05 |
Debt / EBITDA Ratio | 3.66 | 4.12 | 2.74 | 10.33 | 35.20 | 35.15 |
Debt / FCF Ratio | 7.15 | 7.83 | - | - | - | - |
Net Debt / Equity Ratio | 2.87 | 3.07 | 1.96 | 0.77 | 4.11 | 2.30 |
Net Debt / EBITDA Ratio | 3.20 | 3.45 | 1.65 | 4.61 | 33.30 | 26.60 |
Net Debt / FCF Ratio | 6.24 | 6.56 | -10.56 | -1.15 | -2.81 | -2.09 |
Asset Turnover | 0.62 | 0.57 | 0.41 | 0.27 | - | 0.43 |
Inventory Turnover | 1.39 | 1.51 | 1.28 | 0.79 | - | 1.02 |
Quick Ratio | 0.65 | 0.76 | 0.39 | 0.45 | 0.48 | 0.63 |
Current Ratio | 1.65 | 1.83 | 0.60 | 0.76 | 1.00 | 1.24 |
Return on Equity (ROE) | 41.65% | 45.63% | -42.27% | -108.42% | - | -8.74% |
Return on Assets (ROA) | 11.20% | 10.43% | 10.33% | 2.24% | - | -0.24% |
Return on Invested Capital (ROIC) | 16.22% | 20.71% | 39.03% | 7.05% | -0.33% | -0.82% |
Return on Capital Employed (ROCE) | 23.70% | 21.30% | 77.30% | 9.80% | -0.40% | -0.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 |
Earnings Yield | 2.61% | 3.94% | -9.05% | -21.68% | -11.97% | -4.12% |
FCF Yield | 3.47% | 4.96% | -3.13% | -20.62% | -41.87% | -45.31% |
Buyback Yield / Dilution | 3.45% | - | - | -125.00% | - | - |
Total Shareholder Return | 3.45% | - | - | -125.00% | - | - |